Department of Radiology

Publications

2021

Tung C-, Han MS, Shen Z, Gray BD, Pak KY, Wang J. Near-Infrared Fluorogenic Spray for Rapid Tumor Sensing. ACS Sens. 2021;6(10):3657-3666.

Gabr MT, Deganutti G, Reynolds CA. Peptidomimetic-based approach toward inhibitors of microbial trimethylamine lyases. Chem Biol Drug Des. 2021;97(2):231-236.

Rehman AU, Zhen G, Zhong B, Ni D, Li J, Nasir A, et al. Mechanism of zinc ejection by disulfiram in nonstructural protein 5A. Phys Chem Chem Phys. 2021;23(21):12204-12215.

Cheal SM, Patel M, Yang G, Veach DR, Xu H, Guo H-, et al. Correction to An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy. Bioconjug Chem. 2021;32(2):394.

Aboushady Y, Gabr M, ElHady AK, Salah M, Abadi AH, Wilms G, et al. Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases. ACS Chem Neurosci. 2021;12(22):4302-4318.

Kelly JM, Amor-Coarasa A, Sweeney E, Wilson JJ, Causey PW, Babich JW. A suitable time point for quantifying the radiochemical purity of Ac-labeled radiopharmaceuticals. EJNMMI Radiopharm Chem. 2021;6(1):38.

Chen X, Lee SK, Song M, Zhang T, Han MS, Chen Y-, et al. RHAMM-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment. Mol Ther Oncolytics. 2021;23:277-287.

Egan CE, Stefanova D, Ahmed A, Raja VJ, Thiesmeyer JW, Chen KJ, et al. CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer. Thyroid. 2021;31(10):1481-1493.

Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, et al. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications. Bioconjug Chem. 2021;32(4):649-654.

Zhang W, Du B, Gao M, Tung C-. A Hybrid Nanogel to Preserve Lysosome Integrity for Fluorescence Imaging. ACS Nano. 2021;15(10):16442-16451.